National Energy Services Reunited Down Nearly 13%, on Pace for Largest Percent Decrease Since January 2024 -- Data Talk
Dow Jones2026/09/29 17:12National Energy Services Reunited Corp. (NESR) is currently at $25.95, down $3.86 or 12.95%
--Would be lowest close since July 29, 2026, when it closed at $24.41
--On pace for largest percent decrease since Jan. 30, 2024, when it fell 13.1%
--Currently down six of the past seven days
--Currently down five consecutive days; down 21.58% over this period
--Longest losing streak since Sept. 16, 2026, when it fell for five straight trading days
--Worst five day stretch since the five days ending April 8, 2025, when it fell 26.51%
--Down 26.09% month-to-date; on pace for worst month since April 2023, when it fell 42.02%
--Up 65.71% year-to-date
--Down 28.53% from its all-time closing high of $36.31 on Aug. 14, 2026
--Up 152.92% from 52 weeks ago (Sept. 30, 2025), when it closed at $10.26
--Down 28.53% from its 52-week closing high of $36.31 on Aug. 14, 2026
--Up 158.59% from its 52-week closing low of $10.04 on Oct. 9, 2025
--Traded as low as $25.77; lowest intraday level since July 30, 2026, when it hit $25.16
--Down 13.55% at today's intraday low; largest intraday percent decrease since April 4, 2025, when it fell as much as 16.29%
All data as of 1:07:56 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 29, 2026 13:12 ET (17:12 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.